JPMORGAN CHASE & CO - MAINZ BIOMED B V ownership

MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 10 filers reported holding MAINZ BIOMED B V in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of MAINZ BIOMED B V
ValueSharesWeighting
Q3 2023$7,501
+11095.5%
2,569
+18250.0%
0.00%
Q2 2023$67140.00%
Other shareholders
MAINZ BIOMED B V shareholders Q2 2023
NameSharesValueWeighting ↓
Greenwich Investment Management, Inc. 14,724$136,0000.10%
UBS Group AG 1,364$13,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 752$7,0000.00%
View complete list of MAINZ BIOMED B V shareholders